The use of cold coagulation for the treatment of cervical intraepithelial neoplasia
dc.contributor.author | Wyse, A | |
dc.contributor.author | Seah, WA | |
dc.contributor.author | O’Neill, J | |
dc.contributor.author | Byrne, P | |
dc.date.accessioned | 2017-05-17T11:10:03Z | |
dc.date.available | 2017-05-17T11:10:03Z | |
dc.date.issued | 2017-05 | |
dc.identifier.uri | http://hdl.handle.net/10147/621372 | |
dc.description.abstract | In 2015, Cold Coagulation was introduced as a treatment for cervical intraepithelial neoplasia (CIN) at our colposcopy clinic. We reviewed the 6-month follow up data of the first 200 women who underwent Cold Coagulation using cytology and HPV status as tests of cure (TOC). A random sample of 200 patients treated by Large Loop Excision of the Transformation Zone (LLETZ) during the same period was used to compare treatment outcome. Six months following treatment,173 (86.5%) of the women treated by CC and 167 (83.5%) treated by LLETZ had negative cytology. (x2= P>0.05). 148 (74%) treated by Cold Coagulation and 166 (83%) treated by LLETZ were HPV negative (x2= P<0.05). One hundred and thirty-nine (70%) women treated by Cold Coagulation and 152 (76%) treated with LLETZ had normal cytology and were HPV negative. This audit of our initial experience supports the observation that Cold Coagulation is as effective as LLETZ in the management of CIN when cervical cytology is used as a test of cure. | |
dc.language.iso | en | en |
dc.publisher | Irish Medical Journal | en |
dc.subject | CANCER, CERVICAL | en |
dc.subject | WOMEN'S HEALTH | en |
dc.title | The use of cold coagulation for the treatment of cervical intraepithelial neoplasia | en |
dc.type | Article | en |
dc.identifier.journal | Irish Medical Journal | en |
dc.description.funding | No funding | en |
dc.description.province | Leinster | en |
dc.description.peer-review | peer-review | en |
html.description.abstract | In 2015, Cold Coagulation was introduced as a treatment for cervical intraepithelial neoplasia (CIN) at our colposcopy clinic. We reviewed the 6-month follow up data of the first 200 women who underwent Cold Coagulation using cytology and HPV status as tests of cure (TOC). A random sample of 200 patients treated by Large Loop Excision of the Transformation Zone (LLETZ) during the same period was used to compare treatment outcome. Six months following treatment,173 (86.5%) of the women treated by CC and 167 (83.5%) treated by LLETZ had negative cytology. (x2= P>0.05). 148 (74%) treated by Cold Coagulation and 166 (83%) treated by LLETZ were HPV negative (x2= P<0.05). One hundred and thirty-nine (70%) women treated by Cold Coagulation and 152 (76%) treated with LLETZ had normal cytology and were HPV negative. This audit of our initial experience supports the observation that Cold Coagulation is as effective as LLETZ in the management of CIN when cervical cytology is used as a test of cure. |